Nancy B. Amaro-Mugridge

Bacterially Derived 400 nm Particles for Encapsulation and Cancer Cell Targeting of Chemotherapeutics

Jennifer A. MacDiarmid, Nancy B. Amaro-Mugridge, Jocelyn Weiss et al. · Cancer Cell · 2007 · 290 citations · Full text

Nanoparticles, Nanomedicine, Nanotherapeutics +9

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Glen Reid, Marcella Pel, Michaela B. Kirschner et al. · Annals of Oncology · 2013 · 263 citations · Full text

Malignant Pleural Mesothelioma, Novel Approach, Pathology +8

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug

Jennifer A. MacDiarmid, Nancy B. Amaro-Mugridge, Jocelyn Madrid-Weiss et al. · Nature Biotechnology · 2009 · 260 citations

Drug Targeting, Oncology, Medicine +10

Effects of Sequence Alignment and Structural Domains of Ribosomal DNA on Phylogeny Reconstruction for the Protozoan Family Sarcocystidae

Nancy B. Amaro-Mugridge, David A. Morrison, Thomas Jäkel et al. · Molecular Biology and Evolution · 2000 · 110 citations · Full text

Comparative Genomics, Genetics, Molecular Genetics +22

Phylogenetic analysis based on full-length large subunit ribosomal RNA gene sequence comparison reveals that Neospora caninum is more closely related to Hammondia heydorni than to Toxoplasma gondii1Note: Nucleotide sequence data reported in this paper are available in the EMBL, GenBank™ and DDJB databases under the accession numbers AF159240 (Hammondia heydorni), AF101077 (Hammondia hammondi), AF076899 (Sarcocystis tenella) and AF076901 (Toxoplasma gondii ME49 strain).1

Nancy B. Amaro-Mugridge, David A. Morrison, Anja R. Heckeroth et al. · International Journal for Parasitology · 1999 · 99 citations

Biology, Toxoplasma Gondii1note, Me49 Strain +10